Drs. John Chang, William Sandborn and Kim Barrett Honored by American Gastroenterological Association at DDW 2016

Drs. John T. Chang, William J. Sandborn and Kim E. Barrett have received high honors at Digestive Diseases Week® 2016, the annual joint meeting of the American Gastroenterological Association and other gastroenterology and hepatology societies.

John T. Chang, MD

John T. Chang, MD

John T. Chang, MD, Associate Professor of Medicine in the Division of Gastroenterology, was honored with the AGA Young Investigator Award in Basic Science.  |  Read AGA Press Release

The award recognizes Dr. Chang for his originality and innovative insight into basic mechanisms underlying lymphocyte fate specification in systemic and mucosal immune responses.

Dr. Chang is currently exploring whether pharmacologic modulation of proteasome activity might be a useful strategy for improving memory cell generation, highly relevant for mucosal vaccine development.  |  Visit the Chang Laboratory

Dr. William Sandborn

William J. Sandborn, MD

William J. Sandborn, MD, AGAF, received the 2016 AGA Institute Council Immunology, Microbiology & Inflammatory Bowel Diseases (IMIBD) Section Research Mentor Award.

Dr. Sandborn is Professor of Medicine and Chief of the Division of Gastroenterology at UC San Diego.

The AGA Institute Council Intestinal Disorders Section Research Mentor Award went to Kim E. Barrett, PhD, AGAF, Professor of Medicine in the Division of Gastroenterology and Dean of Graduate Studies at UC San Diego.

Kim E. Barrett, PhD

Kim E. Barrett, PhD

The AGA gave its highest honor, the Julius Friedenwald Award, to C. Richard Boland, MD, AGAF, a past leader of the UC San Diego Division of Gastroenterology.

Dr. Boland was Chief of Gastroenterology at UC San Diego from 1995 to 2003.  |  Read the AGA Press Release

Dr. Boland, now at the Baylor University Medical Center in Dallas, TX, received the award for his lifelong contributions to the field of gastroenterology and the AGA.

The American Association for the Study of Liver Diseases (AASLD), American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT) are other sponsoring societies in DDW.

Study Identifies Potential New Class of Drug for Treating Ulcerative Colitis

Oral Drug Shows Clinical Response and Remission in Some Patients

An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The study will appear in the August 16, 2012 issue of the New England Journal of Medicine (NEJM). … Read the full story from the UCSD Newsroom


Dr. William J. SandbornThe principal investigator of the study is Dr. William J. Sandborn, professor of medicine and chief of the Division of Gastroenterology at UCSD.  |  Read his academic profile  |  Read his clinical profile

Read the abstract of the study report in the New England Journal of Medicine

Citation of study report:  Sandborn WJ, Ghosh S, Panes J, Vranic I, Su C, Rousell S, Niezychowski W; Study A3921063 Investigators. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med. 2012 Aug 16;367(7):616-24.